Clinical and experimental dermatology · 2026
Toll-like receptor patterns in epidermodysplasia verruciformis-associated squamous cell carcinomas.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pereira Cibele C A, Fróes Luis Alberto R, Silva Lana Luiza C, Saldanha Maira G, Pereira Naiura V, Oliveira Walmar R P, Sotto Mirian N
Аннотация
BACKGROUND: Epidermodysplasia verruciformis (EV) is a rare genetic condition characterized by viral warts and an increased risk of squamous cell carcinoma (SCC). It is particularly associated with specific human papillomavirus (HPV) types, notably β-HPV variants 5 and 8. Toll-like receptors (TLRs) are crucial for immune response regulation and may contribute to cancer development in EV.
OBJECTIVES: To assess the expression levels of TLR3, -4, -5 and -9 in SCC samples from patients with EV vs. those without EV to understand their potential roles in EV-related carcinogenesis.
METHODS: We examined tumour samples from 18 patients with EV alongside samples from 90 participants without EV. Techniques included tissue microarray analysis and conventional histological evaluation, with immunohistochemistry performed to detect TLR expression. Controls were included to validate the specificity of the results, and statistical analyses employed the Kruskal-Wallis test with Dunn-Bonferroni post hoc comparisons.
RESULTS: TLR3, -4, -5 and -9 were detected in both patient groups, with distinct expression patterns. TLR3 levels were higher in the healthy skin of patients with EV, while TLR9 was more prominent in tumours. In patients without EV, TLR3 and TLR4 expression varied with tumour stages. Invasive SCC showed increased TLR5 and TLR9 levels. EV samples showed significantly higher TLR4 and TLR9 expression than non-EV samples.
CONCLUSIONS: The differing TLR expression patterns indicate diverse immune mechanisms involved in EV-related carcinogenesis. This suggests that TLRs could be potential therapeutic targets, meriting further investigation into their roles in tumour growth regulation.
OBJECTIVES: To assess the expression levels of TLR3, -4, -5 and -9 in SCC samples from patients with EV vs. those without EV to understand their potential roles in EV-related carcinogenesis.
METHODS: We examined tumour samples from 18 patients with EV alongside samples from 90 participants without EV. Techniques included tissue microarray analysis and conventional histological evaluation, with immunohistochemistry performed to detect TLR expression. Controls were included to validate the specificity of the results, and statistical analyses employed the Kruskal-Wallis test with Dunn-Bonferroni post hoc comparisons.
RESULTS: TLR3, -4, -5 and -9 were detected in both patient groups, with distinct expression patterns. TLR3 levels were higher in the healthy skin of patients with EV, while TLR9 was more prominent in tumours. In patients without EV, TLR3 and TLR4 expression varied with tumour stages. Invasive SCC showed increased TLR5 and TLR9 levels. EV samples showed significantly higher TLR4 and TLR9 expression than non-EV samples.
CONCLUSIONS: The differing TLR expression patterns indicate diverse immune mechanisms involved in EV-related carcinogenesis. This suggests that TLRs could be potential therapeutic targets, meriting further investigation into their roles in tumour growth regulation.